Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 10 Sep 21 424B4 Prospectus supplement with pricing info
- 10 Sep 21 EFFECT Notice of effectiveness
-
7 Sep 21 S-1 IPO registration
IMPL similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated March 23, 2021, except for note 14(c) as to which the date is April 19, 2021, in the Registration Statement (Form S-1) and related Prospectus of Impel NeuroPharma, Inc. dated September 7, 2021.
/s/ Ernst & Young LLP
Seattle, Washington
September 7, 2021